[1]马建华,李明,刘宝玲,等.宫颈癌术后容积旋转调强放疗与5野调强放疗计划的剂量学比较[J].国际放射医学核医学杂志,2018,(1):41-46.[doi:10.3760/cma.j.issn.1673-4114.2018.01.008]
 Ma Jianhua,Li Ming,Liu Baoling,et al.Dosimetric comparison between volumetric modulated arc radiotherapy and five fields intensity-modulated radiation therapy for postoperative cervical carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2018,(1):41-46.[doi:10.3760/cma.j.issn.1673-4114.2018.01.008]
点击复制

宫颈癌术后容积旋转调强放疗与5野调强放疗计划的剂量学比较(/HTML)
分享到:

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
期数:
2018年第1期
页码:
41-46
栏目:
临床研究
出版日期:
2018-03-20

文章信息/Info

Title:
Dosimetric comparison between volumetric modulated arc radiotherapy and five fields intensity-modulated radiation therapy for postoperative cervical carcinoma
作者:
马建华 李明 刘宝玲 屠婷婷 尚玉萍 王忠明
222023, 连云港市第二人民医院放疗科
Author(s):
Ma Jianhua Li Ming Liu Baoling Tu Tingting Shang Yuping Wang Zhongming
Department of Radiotherapy, the Second People’s Hospital of Lianyungang, Lianyungang 222023, China
关键词:
宫颈肿瘤容积旋转调强放疗调强放射治疗放射治疗计划剂量学
Keywords:
Uterine cervical neoplasmsVolumetric modulated arc radiotherapyIntensity modulated radiotherapyRadiotherapy planningDosimetrics
DOI:
10.3760/cma.j.issn.1673-4114.2018.01.008
摘要:
目的 比较宫颈癌术后容积旋转调强放疗(VMAT)与5野调强放疗(5F-IMRT)计划的剂量学差异,并在危及器官保护方面进行分析。方法 选择10例宫颈癌术后放疗的5F-IMRT计划,按相同的剂量限制对每例患者行单弧VMAT和双弧VMAT计划设计,比较3种计划的靶区剂量、适形度指数、均匀性指数、危及器官剂量及加速器跳数。组间比较采用单因素方差分析检验,组间两两比较采用LSD检验。结果 单弧VMAT和双弧VMAT均能满足靶区处方剂量的要求,在靶区最大剂量、平均剂量、适形度指数和均匀性指数上,双弧VMAT与5F-IMRT计划相当,单弧VMAT计划最差,差异有统计学意义(F=24.102、13.710、5.919、11.045,均P<0.05);靶区最小剂量比较,3种计划差异无统计学意义(F=3.323,P>0.05)。单弧VMAT和双弧VMAT计划的加速器跳数明显少于5F-IMRT计划,差异有统计学意义(F=295.138,P<0.05)。对于小肠、直肠和膀胱的参数最大剂量,双弧VMAT与5F-IMRT计划相当,单弧VMAT计划最差,差异有统计学意义(F=16.069、7.521、13.966,均P<0.05)。对于膀胱的参数V20、V30和V40(V表示受照剂量体积百分比),5F-IMRT优于单弧VMAT和双弧VMAT,差异有统计学意义(F=5.142、20.095、7.387,均P<0.05)。对于左股骨头参数V20和V30,单弧和双弧VMAT优于5F-IMRT,差异有统计学意义(F=3.717、16.040,均P<0.05)。对于右股骨头参数V30和V40,单弧和双弧VMAT优于5F-IMRT,差异有统计学意义(F=10.873、7.791,均P<0.05)。结论 宫颈癌术后放疗,双弧VMAT计划在靶区剂量学参数上与5F-IMRT计划相当,单弧VMAT计划较差。在危及器官保护方面,3种计划各有优势,但VMAT计划的加速器跳数明显减少,可以提高治疗效率,值得进一步研究。
Abstract:
Objective To determine the dosimetric differences between volumetric modulated arc radiotherapy(VMAT) an five fields intensity-modulated radiation therapy(5F-IMRT) for postoperative cervical cancer. Methods Ten patients with postoperative cervical carcinoma were enrolled in this study. Single arc VMAT, double arc VMAT, and 5F-IMRT plans were generated for these patients. Dose of target, conformal index (CI), homogeneity index (HI), organs at risk and monitor units (MU) were analyzed. The measurement data were analyzed by single factor analysis of variance, and an LSD test was performed in both two groups. Results Single arc and double arc VMAT plans both satisfied the clinical dosimetriy requirements. No significant difference was observed between the VMAT and 5F-IMRT plans with respect to the maximum dose(Dmax) of the target, mean dose(Dmean), CI, and HI. Compared with these plans, the single arc VMAT was weaker and significantly different with respect to the above-mentioned variables (F=24.102, 13.710, 5.919, 11.045, all P<0.05). There is no significant difference between the 3 plans of the minimum dose of the target (F=3.323, P>0.05). The MU values o f the single arc and double arc VMAT plans were significantly lower than that of 5F-IMRT(F=295.138, P>0.05). Meanwhile, significant difference was observed between the Dmax values of the small intestine, rectum, and bladder for double arc VMAT plan, single arc VMAT plan and those of the 5F-IMRT plan(F=16.069, 7.521, 13.966, all P<0.05). The bladder V20, V30 and V40 for 5F-IMRT were better than those of the single arc and double arc VMAT, and the differences were significant(F=5.142, 20.095, 7.387, all P<0.05). The left femoral head V20 and V30 for single arc and double arc VMAT plan was superior to that of 5F-IMRT, and the differences were statistically significant (F=3.717, 16.040, both P<0.05). The right femoral head V30 and V40 for single arc and double arc VMAT plan was superior to that of 5F-IMRT, and the differences were statistically significant (F=10.873, 7.791, both P<0.05). Conclusions Compared with 5F-IMRT, the double arc VMAT achieved equal dosimetric parameters with fewer MU. In terms of organ at risk protection, the three plans have their own advantages, but the MU of the VMAT plan is significantly reduced, which can improve the treatment efficiency and worth further study.

参考文献/References:

[1] 胡尚英, 郑荣寿, 赵方辉, 等. 1989至2008年中国女性子宫颈癌发病率和死亡趋势分析[J]. 中国医学科学院学报, 2014, 36(2):119-125. DOI:10.3881/j.issn.1000-503X.2014.02.001. Hu SY, Zheng RS, Zhao FH, et al. Trend analysis of cervical cancer incidence and mortality rates in Chinese women duri[J]. Acta Academiae Medicinae Sinicae, 2014, 36(2):119-125.
[2] Rotman M, Sedlis A, Piedmonte MR, et al. A phase Ⅲ randomized trial of postoperative pelvic irradiation in Stage IB cervical carcinoma with poor prognostic features:follow-up of a gynecologic oncology group study[J]. Int J Radiat Oncol Biol Phys, 2006, 65(1):169-176. DOI:10.1016/j.ijrobp.2005.10.019.、
[3] 金华, 马翔宇, 周丽静, 等. 调强放疗在早期子宫颈癌术后阴道残端复发治疗中的价值[J]. 肿瘤研究与临床, 2014, 26(4):238-240. DOI:10.3760/cma.j.issn.1006-9801.2014.04.007. Jin H, Ma XY, Zhou LJ, et al. Evaluation of the intensity modulated radiotherapy in early stage cervical cancer with vaginal stump recurrence after surgery[J]. Cancer Res Clin, 2014, 26(4):238-240.
[4] 穆鹏, 李联崑, 贾海清. 宫颈癌术后调强放疗与三维适形放疗的对比研究[J]. 实用医院临床杂志, 2015, 12(2):49-51, 52. DOI:10.3969/j.issn.1672-6170.2015.02.018. Mu P, Li LK, Jia HQ. A comparative study on three-dimensional conformal radiotherapy and intensity modulated radiotherapy in the treatment of postoperative cervical cancer[J]. Pract J Clin Med, 2015, 12(2):49-51, 52.
[5] Yu CX. Intensity-modulated arc therapy with dynamic multileaf collimation:an alternative to tomotherapy[J]. Phys Med Biol, 1995, 40(9):1435-1449.
[6] Otto K. Volumetric modulated arc therapy:IMRT in a single gantry arc[J]. Med Phys, 2008, 35(1):310-317. DOI:10.1118/1.2818738.
[7] Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium[J]. Int J Gynaecol Obstet, 2009, 105(2):103-104. DOI:10.1016/j.ijgo.2009.02.012.
[8] Wang JZ, Li XA, D’Souza WD, et al. Impact of prolonged fraction delivery times on tumor control:a note of caution for intensity-modulated radiation therapy (IMRT)[J]. Int J Radiat Oncol Biol Phys, 2003, 57(2):543-552.
[9] Moiseenko V, Duzenli C, Durand RE. In vitro study of cell survival following dynamic MLC intensity-modulated radiation therapy dose delivery[J]. Med Phys, 2007, 34(4):1514-1520. DOI:10.1118/1.2712044.
[10] Guckenberger M, Richter A, Krieger T, et al. Is a single arc sufficient in volumetric-modulated arc therapy(VMAT) for complex-shaped target volumes?[J]. Radiother Oncol, 2009, 93(2):259-265. DOI:10.1016/j.radonc.2009.08.015.
[11] Shaffer R, Nichol AM, Vollans E, et al. A comparison of volumetric modulated arc therapy and conventional intensity-modulated radiotherapy for frontal and temporal high-grade gliomas[J]. Int J Radiat Oncol Biol Phys, 2010, 76(4):1177-1184. DOI:10.1016/j.ijrobp.2009.03.013.
[12] 杨波, 庞廷田, 孙显松, 等. 宫颈癌术后盆腔容积调强弧形治疗与固定野调强放疗计划的剂量学研究[J]. 中华放射肿瘤学杂志, 2012, 21(6):543-546. DOI:10.3760/cma.j.issn.1004-4221. 2012. 06.018. Yang B, Pang TT, Sun XS, et al. Dosimetric study of volumetric intensity-modulated arc therapy and fixed field intensity-modulated radiotherapy for cervix cancer[J]. Chin J Radiat Oncol, 2012, 21(6):543-546.
[13] 杨国姿, 潘振宇, 夏文明, 等. 容积旋转调强与固定野动态调强在宫颈癌术后放疗的剂量学比较[J]. 中华放射医学与防护杂志, 2014, 34(1):37-40. DOI:10.3760/cma.j.issn.0254-5098. 2014. 01.010. Yang GZ, Pan ZY, Xia WM, et al. Dosimetric comparison and clinical application of RapidArc and intensity-modulated radiotherapy for postoperative radiotherapy of cervical cancer[J]. Chin J Radiol Med Prot, 2014, 34(1):37-40.
[14] 吴丽丽, 谢文佳, 张武哲, 等. 宫颈癌根治性放疗旋转容积调强技术及固定野动态调强放疗技术的剂量学差异[J]. 中国老年学杂志, 2014, 34(10):2617-2620. DOI:10.3969/j.issn.1005-9202. 2014.10.001. Wu LL, Xie WJ, Zhang WZ, et al. Dosimetric study of volumetric modulated radiotherapy in cervical cancer treated with definitive radiotherapy[J]. Chin J Gerontol, 2014, 34(10):2617-2620.
[15] 康梅, 权循凤, 李兵兵, 等. 宫颈癌容积调强与固定野动态调强放疗技术的剂量学比较[J]. 安徽医学, 2016, 37(4):398-402. DOI:10.3969/j.issn.1000-0399.2016.04.005. Kang M, Quan XF, Li BB, et al. Dosimetric study of volumetric-modulated arc radiotherapy and fixed field-intensity modulated radiation therapy for cervix neoplasms[J]. Anhui Med J, 2016, 37(4):398-402.
[16] Jia MX, Zhang X, Yin C, et al. Peripheral dose measurements in cervical cancer radiotherapy:a comparison of volumetric modulated arc therapy and step-and-shoot IMRT techniques[J/OL]. Radiat Oncol, 2014, 9:61[2017-10-15]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996072. DOI:10.1186/1748-717X-9-61.
[17] Sharfo AW, Voet PW, Breedveld S, et al. Comparison of VMAT and IMRT strategies for cervical cancer patients using automated planning[J]. Radiother Oncol, 2015, 114(3):395-401. DOI:10.1016/j.radonc.2015.02.006.

相似文献/References:

[1]黄维,李英,龙强,等.中晚期宫颈癌患者调强放疗与同步推量调强放疗预后比较[J].国际放射医学核医学杂志,2016,40(6):429.[doi:10.3760/cma.j.issn.1673-4114.2016.06.006]
 Huang Wei,Li Ying,Long Qiang,et al.Clinical effects of IMRT and simultaneous integrated boost-intensity modulated radiation therapy:a comparative study of 277 patients with advanced cervical cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):429.[doi:10.3760/cma.j.issn.1673-4114.2016.06.006]
[2]刘道佳,唐明灯,林端瑜,等.18F-FDG SPECT-CT在宫颈癌监测中的价值[J].国际放射医学核医学杂志,2010,34(3):155.
 LIU Dao-jia,TANG Ming-deng,LIN Duan-yu,et al.The value of 18F-FDG SPECT-CT in detecting recurrence or metastasis of cervical cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(1):155.
[3]黄建敏,潘莉萍,李冬雪.PET和PET-CT在宫颈癌中的应用价值[J].国际放射医学核医学杂志,2007,31(2):112.
 HUANG Jian-min,PAN Li-ping,LI Dong-xue.The application of PET and PET-CT in cervical cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2007,31(1):112.
[4]李红艳,贺桂芳,陈志华.宫颈癌辐射敏感性相关基因的研究进展[J].国际放射医学核医学杂志,2007,31(1):44.
 LI Hong-yan,HE Gui-fang,CHEN Zhi-hua.The development of genes associated with radiosensitivity of cervical cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2007,31(1):44.
[5]龙斌,肖必文.前哨淋巴结检测术在宫颈癌诊疗中的研究进展[J].国际放射医学核医学杂志,2007,31(3):166.
 LONG Bin,XIAO Bi-wen.Advances in sentinel lymph node detection to cervical cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2007,31(1):166.
[6]陈冀莹.宫颈癌基因治疗联合放射治疗的研究进展[J].国际放射医学核医学杂志,2006,30(6):365.
 CHEN Ji-ying.Progress of cervical cancer genetic-radiotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2006,30(1):365.
[7]薛艳,安瑞芳.放射免疫显像在妇科肿瘤中的研究与应用[J].国际放射医学核医学杂志,2006,30(1):36.
 XUE Yan,AN Rui-fang.A research on radioimmunoimaging and its application in diagnosis of gynecological tumors[J].International Journal of Radiation Medicine and Nuclear Medicine,2006,30(1):36.
[8]姜勉,董佳丽,李航,等.HBXIP蛋白表达对宫颈癌细胞的增殖能力及放射敏感性的影响[J].国际放射医学核医学杂志,2017,41(5):340.[doi:10.3760/cma.j.issn.1673-4114.2017.05.007]
 Jiang Mian,Dong Jiali,Li Hang,et al.Effects of HBXIP protein expression on the proliferation and radiosensitivity of cervical cancer cells[J].International Journal of Radiation Medicine and Nuclear Medicine,2017,41(1):340.[doi:10.3760/cma.j.issn.1673-4114.2017.05.007]

备注/Memo

备注/Memo:
收稿日期:2017-10-17。
通讯作者:王忠明,Email:wzm85365580@126.com
更新日期/Last Update: 2018-03-20